Holen Sie sich die Stockscreener-App
23.60
2.35%
0.60
Handel nachbörslich:
23.60
Schlusskurs vom Vortag:
$23.00
Offen:
$23.28
24-Stunden-Volumen:
209.23K
Relative Volume:
0.67
Marktkapitalisierung:
$1.38B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+5.47%
1M Leistung:
-13.84%
6M Leistung:
+41.55%
1J Leistung:
+0.00%
1-Tages-Spanne:
$22.68
$24.08
1-Wochen-Bereich:
$22.10
$24.08
52-Wochen-Spanne:
$13.25
$30.00
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
Firmenname
Kestra Medical Technologies Ltd
Sektor
Telefon
(425) 279-8002
Adresse
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
Vergleichen Sie KMTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KMTS
Kestra Medical Technologies Ltd
|
23.60 | 1.34B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
523.69 | 186.98B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
206.18 | 57.95B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.62 | 38.83B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.31 | 36.96B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.30 | 36.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | BTIG Research | Buy |
| 2025-03-31 | Eingeleitet | BofA Securities | Buy |
| 2025-03-31 | Eingeleitet | Goldman | Neutral |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-03-31 | Eingeleitet | Stifel | Buy |
| 2025-03-31 | Eingeleitet | Wells Fargo | Overweight |
| 2025-03-31 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Kestra Medical Technologies Ltd Aktie (KMTS) Neueste Nachrichten
Published on: 2026-01-21 23:54:20 - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Insider Brian Daniel Webster Sells 15,000 Shares - Defense World
Short Interest in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Rises By 21.5% - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Sees Large Growth in Short Interest - MarketBeat
Should value investors consider Kestra Medical Technologies Ltd.July 2025 Trade Ideas & Weekly High Return Forecasts - bollywoodhelpline.com
Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery - Yahoo Finance
Kestra Medical partners with Biobeat to add blood pressure monitoring By Investing.com - Investing.com Nigeria
KMTS: Strong clinical data and innovation drive rapid growth and margin expansion in the WCD market - TradingView — Track All Markets
Kestra Medical partners with Biobeat to add blood pressure monitoring - Investing.com
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery - GlobeNewswire
72% of heart recovery patients are hypertensive in Kestra BP tech deal - Stock Titan
Market Rankings: Will Kestra Medical Technologies Ltd outperform its industry peersPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6% – What’s Next? - Defense World
Goldman Sachs Maintains Kestra Medical Technologies(KMTS.US) With Hold Rating, Raises Target Price to $27 - 富途牛牛
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6%Time to Sell? - MarketBeat
Is Kestra Medical Technologies Ltd. stock positioned for long term growthEarnings Risk Report & Weekly Hot Stock Watchlists - ulpravda.ru
Will Kestra Medical Technologies Ltd. stock return to pre crisis levelsJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6.1% – Here’s Why - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6.1%Here's What Happened - MarketBeat
Traci Umberger Sells 10,500 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Brian Daniel Webster Sells 15,000 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Webster, Kestra medical CEO, sells $398k in shares By Investing.com - Investing.com Australia
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 10,500 Shares of Stock - MarketBeat
Kestra Medical Technologies Insider Sold Shares Worth $280,201, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies Insider Sold Shares Worth $398,847, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Both Private Equity Firms Who Control a Good Portion of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Along With Institutions Must Be Dismayed After Last Week's 3.1% Decrease - 富途牛牛
Biobeat Technologies Ltd. announced that it has received $50 million in funding from Ally Bridge Group, OrbiMed Advisors LLC, Elevage Medical Technologies, Kestra Medical Technologies, Ltd. and other investors - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Can Kestra Medical Technologies Ltd. stock maintain operating margins2025 Volume Leaders & AI Driven Stock Reports - Улправда
Will Kestra Medical Technologies Ltd. stock benefit from AI adoptionJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M - MSN
Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb? - Sahm
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Technologies reports strong earnings growth - MSN
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpHere's What Happened - MarketBeat
Kestra Medical Technologies (KMTS) Q2: Revenue Growth, Losses Deepen, Testing Bullish Scale Narratives - Sahm
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Reports Strong Earnings Growth - TipRanks
Wells Fargo Raises Price Target for KMTS, Maintains Overweight R - GuruFocus
Kestra Medical price target raised to $30 from $27 at Piper Sandler - MSN
Kestra Medical Technologies stock price target raised by Stifel to $30 - Investing.com Australia
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler By Investing.com - Investing.com South Africa
Kestra Medical Technologies stock price target raised to $30 from $27 at Piper Sandler - Investing.com Australia
Kestra Medical Technologies: Strong Financial Performance and Market Leadership Drive Buy Rating - TipRanks
Finanzdaten der Kestra Medical Technologies Ltd-Aktie (KMTS)
Es liegen keine Finanzdaten für Kestra Medical Technologies Ltd (KMTS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):